Published in Eur J Gastroenterol Hepatol on May 01, 1996
Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology (2001) 5.80
Methodological issues in studies of air pollution and daily counts of deaths or hospital admissions. J Epidemiol Community Health (1996) 4.44
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health (1996) 3.90
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med (2001) 3.40
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Evidence for interaction between air pollution and high temperature in the causation of excess mortality. Arch Environ Health (1993) 2.67
Time-series analysis of air pollution and cause-specific mortality. Epidemiology (1998) 2.60
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J (1997) 2.43
HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill (2011) 2.42
Urban air pollution and emergency admissions for asthma in four European cities: the APHEA Project. Thorax (1997) 2.31
Short-term effects of nitrogen dioxide on mortality: an analysis within the APHEA project. Eur Respir J (2006) 2.00
Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill (2009) 1.98
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J Med Virol (1999) 1.77
Short-term effects of air pollution on mortality in Athens. Int J Epidemiol (1986) 1.61
Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Air Pollution and Health: a European Approach. Arch Environ Health (1998) 1.59
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology (1987) 1.44
Increased liver decompensation risk with atypical hepatitis C virus antibody levels. J Infect Dis (2000) 1.41
Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus. J Hepatol (1994) 1.40
Attitudes of a Mediterranean population to the truth-telling issue. J Med Ethics (1992) 1.39
The 1987 Athens heatwave. Lancet (1988) 1.39
Air pollution and cause specific mortality in Athens. J Epidemiol Community Health (1990) 1.38
A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction (1998) 1.30
Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology (1991) 1.29
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis (1999) 1.27
School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. Euro Surveill (2009) 1.24
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods (2002) 1.20
Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA (1991) 1.20
Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol (1992) 1.18
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer (1996) 1.18
Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J Clin Microbiol (1987) 1.18
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis (1988) 1.15
The temporal pattern of mortality responses to ambient ozone in the APHEA project. J Epidemiol Community Health (2009) 1.13
Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet (2000) 1.13
The validity of gynecological ultrasonography. Gynecol Obstet Invest (1990) 1.12
Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM (2000) 1.12
Short-term effects of ambient particles on mortality in the elderly: results from 28 cities in the APHEA2 project. Eur Respir J Suppl (2003) 1.12
Investigating the dose-response relation between air pollution and total mortality in the APHEA-2 multicity project. Occup Environ Med (2003) 1.10
Investigating regional differences in short-term effects of air pollution on daily mortality in the APHEA project: a sensitivity analysis for controlling long-term trends and seasonality. Environ Health Perspect (2001) 1.10
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat (2006) 1.08
Effects of lead on the somatic growth of children. Arch Environ Health (1998) 1.06
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol (1990) 1.03
Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol (1996) 1.02
A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect (2008) 1.02
Fulminant hepatitis due to Epstein-Barr virus infection. J Hepatol (1995) 1.02
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study. Aliment Pharmacol Ther (2009) 0.99
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat (2005) 0.98
Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis (2001) 0.98
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol (1995) 0.98
Passive smoking and chronic obstructive lung disease. Lancet (1987) 0.97
HIV epidemiology in Greece. Future Microbiol (2008) 0.96
Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study. AIDS (1998) 0.96
Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA (1992) 0.95
The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer (1997) 0.95
Searching for West Nile virus (WNV) in Greece. Transfus Med (2009) 0.95
Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology. J Clin Microbiol (2009) 0.95
Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol (2001) 0.94
Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. J Viral Hepat (2004) 0.94
SlidingBayes: exploring recombination using a sliding window approach based on Bayesian phylogenetic inference. Bioinformatics (2004) 0.93
Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant (1996) 0.93
Time trends of tobacco smoking, air pollution, and lung cancer in Athens. Environ Res (1987) 0.92
Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother (2003) 0.91
The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer (1999) 0.91
Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Virol Methods (2001) 0.90
Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med (2000) 0.89
Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2. J Viral Hepat (2015) 0.89
Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies. Euro Surveill (2009) 0.89
HBcAg and HBsAg expression in ductular cells in chronic hepatitis B. Liver (1994) 0.88
Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study. Hippokratia (2011) 0.88
Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group. J Infect Dis (1993) 0.87
Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. J Med Virol (1998) 0.86
Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C. Aliment Pharmacol Ther (2006) 0.86
Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. Liver (2001) 0.86
Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology (1992) 0.86
Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand J Infect Dis (1996) 0.86
Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg (1999) 0.86
Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant (1999) 0.86
Unusual CD4+CD8+ phenotype in a greek patient diagnosed with adult T-cell leukemia positive for human T-cell leukemia virus type I (HTLV-I). Leuk Res (2000) 0.86
Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. AIDS Res Hum Retroviruses (1999) 0.86